Holen Sie sich die Stockscreener-App
13.66
3.64%
0.48
Schlusskurs vom Vortag:
$13.18
Offen:
$13.16
24-Stunden-Volumen:
1.14M
Relative Volume:
1.09
Marktkapitalisierung:
$1.06B
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$40.23M
KGV:
27.32
EPS:
0.5
Netto-Cashflow:
$60.93M
1W Leistung:
+1.26%
1M Leistung:
+12.15%
6M Leistung:
-2.29%
1J Leistung:
-43.11%
1-Tages-Spanne:
$12.73
$13.88
1-Wochen-Bereich:
$12.73
$13.88
52-Wochen-Spanne:
$10.87
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Firmenname
Integra Lifesciences Holdings Corp
Sektor
Branche
Telefon
(609) 275-0500
Adresse
1100 CAMPUS ROAD, PRINCETON, NJ
Vergleichen Sie IART mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
13.66 | 1.03B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Underweight |
| 2024-10-07 | Hochstufung | BTIG Research | Sell → Neutral |
| 2024-07-30 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-07-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-05-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-12-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Eingeleitet | CL King | Buy |
| 2023-08-24 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-08 | Herabstufung | Argus | Buy → Hold |
| 2023-05-24 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-25 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2021-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Eingeleitet | Citigroup | Neutral |
| 2020-04-03 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Eingeleitet | SunTrust | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-07 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-07-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Eingeleitet | UBS | Buy |
Alle ansehen
Integra Lifesciences Holdings Corp Aktie (IART) Neueste Nachrichten
How Integra LifeSciences Holdings Corporation (IL3) stock responds to bond marketWeekly Trade Summary & Accurate Entry and Exit Point Alerts - Newser
Will Integra LifeSciences Holdings Corporation (IL3) stock test record highs in 2025Forecast Cut & AI Based Buy and Sell Signals - Newser
Adversity is less terrifying than hope: Integra Lifesciences Holdings Corp (IART) - Setenews
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference - The Manila Times
Integra LifeSciences (Nasdaq: IART) slated for Citi 2025 Global Healthcare Conference - Stock Titan
How does Integra Lifesciences Holdings Corp (IART) change from a tortoise to a hare? - Setenews
A Fresh Look at Integra LifeSciences (IART) Valuation After Recent Share Price Volatility - Yahoo Finance
Integra LifeSciences Drops After Cutting Revenue Outlook - Finimize
Integra LifeSciences (IART) Welcomes CMS Inclusion of Key Produc - GuruFocus
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - Finviz
Integra LifeSciences Applauds CMS Ruling on Medicare Payment Schedule Benefiting Skin Substitute Products - Quiver Quantitative
Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know - Yahoo Finance
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know - Barchart.com
How robust is Integra LifeSciences Holdings Corporation (IL3) stock financial positionAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Why Integra LifeSciences Holdings Corporation stock is recommended by analystsEarnings Summary Report & Weekly Stock Performance Updates - newser.com
Is Integra LifeSciences Holdings Corporation (IL3) stock vulnerable to rate hikes - newser.com
Prepare Yourself for Liftoff: Acadia Healthcare Company Inc (ACHC) - Setenews
How institutional ownership impacts Integra LifeSciences Holdings Corporation stock2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
Is Integra LifeSciences Holdings Corporation stock cheap at current valuation2025 Bull vs Bear & Safe Swing Trade Setups - newser.com
Does Integra LifeSciences Holdings Corporation show high probability of reboundJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
How buyback programs support Integra LifeSciences Holdings Corporation (IL3) stockTrade Analysis Report & Risk Managed Investment Signals - newser.com
FDA Grants 510(k) Clearance to Ultrasonic Surgical Aspirator System for Cardiac Surgeries - Diagnostic and Interventional Cardiology
Surgical Equipment & ConsumablesSpecialty Stocks Q3 Recap: Benchmarking Integra LifeSciences (NASDAQ:IART) - Yahoo Finance
Is Integra LifeSciences Holdings Corporation stock vulnerable to regulatory risksJuly 2025 Summary & Verified Momentum Watchlists - newser.com
Is Integra LifeSciences Holdings Corporation stock a buy for dividend growthWeekly Trade Summary & Real-Time Buy Signal Notifications - newser.com
Integra LifeSciences Holdings Corporation stock volume spike explainedStop Loss & Expert Verified Movement Alerts - newser.com
Integra LifeSciences (IART) Stock Trades Up, Here Is Why - Finviz
Nothing is Better Than Integra Lifesciences Holdings Corp (IART) stock at the moment - Setenews
Integra LifeSciences (IART) Gains FDA Clearance for Cardiac Surg - GuruFocus
Integra LifeSciences stock jumps after FDA clearance for cardiac surgery device By Investing.com - Investing.com South Africa
Integra LifeSciences stock jumps after FDA clearance for cardiac surgery device - Investing.com
Integra LifeSciences Receives FDA Clearance for CUSA Clarity Ultrasonic Surgical Aspirator in Cardiac Surgery Applications - Quiver Quantitative
Integra LifeSciences Receives FDA 510(k) Clearance for Use - GlobeNewswire
Regenerative Medicine Market Research Report 2025 Featuring Stryker, Athersys, Integra Lifesciences, Isto Biologics, Organogenesis, CryoLife, Medtronic, U.S. Stem Cell, Zimmer Biomet, and 3M - Yahoo Finance
Is Integra LifeSciences Holdings Corporation stock poised for growth2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com
Finanzdaten der Integra Lifesciences Holdings Corp-Aktie (IART)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):